SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-295865
Filing Date
2014-08-05
Accepted
2014-08-05 16:31:17
Documents
12
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d755640d10q.htm 10-Q 411150
2 EX-10.1 d755640dex101.htm EX-10.1 42896
3 EX-31.1 d755640dex311.htm EX-31.1 8615
4 EX-31.2 d755640dex312.htm EX-31.2 8882
5 EX-32.1 d755640dex321.htm EX-32.1 5198
12 GRAPHIC g755640g27x02.jpg GRAPHIC 2671
  Complete submission text file 0001193125-14-295865.txt   3248349

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT snss-20140630.xml EX-101.INS 403223
7 XBRL TAXONOMY EXTENSION SCHEMA snss-20140630.xsd EX-101.SCH 38653
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE snss-20140630_cal.xml EX-101.CAL 53292
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snss-20140630_def.xml EX-101.DEF 101182
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE snss-20140630_lab.xml EX-101.LAB 289786
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snss-20140630_pre.xml EX-101.PRE 190306
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51531 | Film No.: 141016563
SIC: 2834 Pharmaceutical Preparations